Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astaxanthin as Adjuvant Therapy for Community Acquired Pneumonia
NCT06334874Phase 4Recruiting
- Sponsor
- Future University in Egypt
- Start
- Apr 2024
- Primary completion
- Jul 2024
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of astaxanthin in community acquired pneumonia (CAP), sponsored by Future University in Egypt. Started Apr 2024; status: recruiting.
02
Drugs
astaxanthin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT06334874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06334874.